Predictive genomic markers to chemotherapy and adjuvant trastuzumab via whole genome expression DASL profiling in the N9831 adjuvant study
- Citation:
- Cancer Res vol 72 (24 supplement) PD10-04
- Meeting Instance:
- AACR 2012
- Year:
- 2012
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2079
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- E. Perez J. Eckel-Passow K. Ballman S. Anderson E. Thompson Y. Asmann J. Jen A. Dueck W. Lingle G. Sledge E. Winer J. Gralow R. Jenkins M. Reinholz
- Networks:
- Study
- NCCTG-N9831
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: